Hospital for Special Surgery Added to Aetna Provider Network.

HEALTH AND BEAUTY CLOSE-UP-8 July 2008-Hospital for Special Surgery Added to Aetna Provider Network(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Aetna and Hospital for Special Surgery (HSS) announced a new agreement on a three-year contract that adds the hospital to Aetna's provider

network.

The agreement became effective July 1, the groups noted.

"We are very pleased that with this agreement, members of Aetna's network-based commercial plans will be able to receive covered patient services, at in-network rates, from Hospital for Special Surgery," said Michael Hudson, president of Aetna's Northeast Region. The agreement does not apply to Aetna's Medicare members or to its workers compensation business products.

"This agreement further strengthens Aetna's robust metro-New York network, adding the world's leading hospital for orthopedics and rheumatology and a growing number of orthopedic surgeons and rheumatologists who practice at HSS, as well as HSS departments of anesthesiology, radiology, rehabilitation and pathology," said Glenn Pomerantz, MD, JD, regional medical director, Aetna Northeast. "HSS is widely recognized for its high quality care and outcomes, and we believe the addition of this hospital to our network will come as great news to our members across the country."

According to a release, Hospital for Special Surgery is located in Manhattan. The 162 bed hospital, which pioneered the first modern total knee replacement, was ranked number one in orthopedics and number three in rheumatology by U.S. News & World Report magazine in its 2007 "America's Best Hospitals" survey. Areas of expertise, in addition to joint replacement, include spine surgery, sports medicine, orthopedic trauma, hand surgery and foot and ankle surgery.

"HSS is committed to providing exceptional patient care," said Louis A. Shapiro, president and CEO, Hospital for Special Surgery. "We are pleased that Aetna members will have the opportunity to access our services on an in-network basis and we look forward to a positive, long-term relationship with Aetna for the benefit of its members."

((Comments on this story may be sent to health@closeupmedia.com))

((Distributed via M2 Communications Ltd - http://www.m2.com))

Related Articles

  • BRIEFLY.
  • Byline: The Register-Guard PacificSource adds hospitals, doctors to list of providers PacificSource Health Plans has added Providence Health System's four Portland area hospitals and two physician groups to its participating provider network. New participating hospitals include Providence Portland Medical Center, ......
  • Helping elderly cope with hip fractures.
  • "Many elderly patients who break a hip face a broad array of problems that transcend the treatment of the injury itself," points out Thomas P. Sculco, a clinical professor in the Department of Orthopaedic Surgery, Cornell University Medical College and ......
  • New treatment for painful heel bumps.
  • These days, as ever, the sport of running comes with aches, pains, and conditions for which we seek immediate and long-term remedy. However, the bright future is always around the bend, with almost constant advancements in medicine that keep us ......
  • Inefficient protein tied to lupus.
  • Systemic lupus erythematosus, the autoimmune disease so savage it was named for the wolf, baffles researchers, who do not know why it affects some people more severely than others. Now, a study by researchers at five major medical centers offers ......
  • Osteopontin polymorphism is linked to disease course in o-JIA.
  • A gene polymorphism of the phosphorylated glycoprotein, osteopontin, appears to be associated with the prognosis of oligoarticular-onset juvenile idiopathic arthritis, but more data are needed before it is considered a reliable disease marker. Osteopontin, which was recently proposed to be ......
  • New total hip arthroplasty technique promising.
  • CHICAGO -- Less invasive hip arthroplasty techniques continue to progress and offer new advantages for patients, said Dr. Bryan J. Nestor. Anterior two-incision total hip arthroplasty (THA), only recently touted as being "revolutionary," is falling into disfavor and many surgeons ......
  • Bone matrix trial represents a first, says Osteotech.
  • The first prospective randomized clinical trial ever conducted with a demineralized bone matrix (DBM) in a carrier represents a significant step forward in the field, as it provides a means of comparing a specific DBM product with autograft, said the ......
  • Patients followed for up to 5 years: risedronate therapy preserves bone quality.
  • MINNEAPOLIS -- Long-term risedronate therapy appears to preserve bone quality, according to the findings of a small, industry-sponsored study presented at the annual meeting of the American Society for Bone and Mineral Research. Together with previously published evidence of enhanced ......
  • Risedronate therapy preserves bone quality: values unchanged at 5 years.
  • MINNEAPOLIS -- Long-term risedronate therapy appears to preserve bone quality, according to the findings of a small, industry-sponsored study presented at the annual meeting of the American Society for Bone and Mineral Research. Together with previously published evidence of enhanced ......
  • Long-term treatment with risedronate preserves bone quality: patients followed for up to 5 years.
  • MINNEAPOLIS -- Long-term risedronate therapy appears to preserve bone quality, according to the findings of a small, industry-sponsored study presented at the annual meeting of the American Society for Bone and Mineral Research. Together with previously published evidence of enhanced ......
  • Still looking for cancer immunotherapy.
  • Still looking for cancer immunotherapy An estimated three out of four families in the United Stateswill be directly affected by cancer, says the American Cancer Society. But, thanks to aggressive cancer research, innovative approaches to cure and treatment of the ......
  • Israeli firm Impliant wins funding.
  • Israeli medical device manufacturer Impliant Inc is developing a new class of spine and joint arthroplasty devices, through its use of innovative polymer materials and engineering techniques. Chief Executive Officer Ron Sacher believes these products will revolutionize the field of ......
  • Angiogenic imbalances predict preedampsia in SLE pregnancies.
  • BOSTON -- Alterations in circulating antiangiogenic protein levels in pregnant women with lupus and antiphospholipid antibody syndrome may predict preeclampsia, a complication for which they are at increased risk, according to data presented at the annual meeting of the American ......
  • Bionx starts sales of its polymer bone fracture nail.
  • Bionx Implants is introducing a resorbable polymer fixation device for use with small bone fractures, osteochondral fragments or osteochondritis dissecans lesions. The device, SmartNail(tm), can be delivered arthroscopically. This makes the operation less complicated and reduces the risk of dying ......
  • Individuals with amputations find rehabilitation in competitive sports.
  • Individuals with Amputations Find Rehabilitation in Competitive Sports Participation in athletic competition has emerged as an important tool of rehabilitation for scores of persons with lower-limb amputations. The combination of traditional and modern rehabilitation methods, state-of-the-art dynamic response prostheses and ......

Related Topics